Sui Shen - Concepedia

Author

Sui Shen

University of Alabama at Birmingham ORCID

Also Known As

S SHEN, S Shen, S. Shen, SUI SHEN, Shuqi Shen, Stephanie Shen, Sui Shen

283

Publications

5.1K

Citations

H-Index

Concepts

All Affiliations

University of Alabama at Birmingham University of California, Davis University of California Davis Medical Center Palmetto Hematology Oncology University of Alabama

About

Sui Shen is an author at University of Alabama at Birmingham specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	20	29	1.1K
2	Health Sciences	17	22	776
3	Engineering	5	5	197
4	Biomedical Engineering	3	3	124
5	Cell Biology	2	2	109

Sui Shen

Publications

4.9K

Citations

H-Index

Page 1

	Year	Citations
Evidence for linkage of bipolar disorder to chromosome 18 with a parent-of-origin effect. O. Colin Stine, Jianfeng Xu, Rebecca Koskela, PubMed	1995	346
Phase I Single-Dose Study of Intracavitary-Administered Iodine-131-TM-601 in Adults With Recurrent High-Grade Glioma Adam N. Mamelak, Steven S. Rosenfeld, Richard D. Bucholz, Journal of Clinical Oncology	2006	215
Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma. Gerald L. DeNardo, Sally J. DeNardo, D S Goldstein, Journal of Clinical Oncology	1998	182
Dosimetric effect of respiration‐gated beam on IMRT delivery Jun Duan, Sui Shen, John B. Fiveash, Medical Physics	2003	163
Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma Andres Forero, Paul L. Weiden, Julie M. Vose, Blood	2004	149
Pharmacokinetics and Imaging of <sup>212</sup> Pb-TCMC-Trastuzumab After Intraperitoneal Administration in Ovarian Cancer Patients Ruby F. Meredith, Julien Torgue, Michael Azure, Cancer Biotherapy and Radiopharmaceuticals	2013	133
Dose Escalation and Dosimetry of First-in-Human α Radioimmunotherapy with <sup>212</sup>Pb-TCMC-Trastuzumab Ruby F. Meredith, Julien Torgue, Sui Shen, Journal of Nuclear Medicine	2014	125
A Phase I study of combined modality (90)Yttrium-CC49 intraperitoneal radioimmunotherapy for ovarian cancer. Ronald D. Alvarez, Warner K. Huh, M.B. Khazaeli, PubMed	2002	110
Low-dose, Fractionated Radioimmunotherapy for B-cell Malignancies using <sup>131</sup> I-LYM-1 Antibody Gerald L. DeNardo, Sally J. DeNardo, Kathleen R. Lamborn, Cancer Biotherapy and Radiopharmaceuticals	1998	95
Planar gamma camera imaging and quantitation of yttrium-90 bremsstrahlung. Sui Shen, Gerald L. DeNardo, A. Yuan, PubMed	1994	93

Page 1